| Literature DB >> 19517268 |
Rianne Hoopman1, Caroline B Terwee, Walter Devillé, Dirk L Knol, Neil K Aaronson.
Abstract
PURPOSE: To evaluate the psychometrics of the SF-36 Health Survey among Turkish and Moroccan ethnic minority populations in the Netherlands and to compare the results to those based on the indigenous Dutch population.Entities:
Mesh:
Year: 2009 PMID: 19517268 PMCID: PMC2704293 DOI: 10.1007/s11136-009-9491-1
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Fig. 1Overview of sampling and response of the Turkish and Moroccan groups
Respondent background characteristics
| Turkish ( | Moroccan ( | Turkish language subgroup ( | Moroccan-Arabic language subgroup ( | Dutch ( | |
|---|---|---|---|---|---|
| Gender | |||||
| Female | 215 (53%) | 196 (52%) | 95 (59%) | 34 (65%) | 5,334 (55%) |
| Male | 194 (47%) | 181 (48%) | 67 (41%) | 18 (35%) | 4,294 (45%) |
| Age mean (sd) | 36.8 (12.1) | 36.6 (12.6) | 40.5 (12.9) | 41.4 (12.0) | 48.9 (17.0) |
| Age range | 18–76 | 18–79 | 21–69 | 20–67 | 18–79 |
| Age | |||||
| 18–49 | 331 (81%) | 316 (84%) | 114 (70%) | 39 (75%) | 5,149 (54%) |
| 50–79 | 77 (19%) | 60 (16%) | 47 (29%) | 12 (23%) | 4,478 (46%) |
| Missing | 1 (0.2%) | 1 (0.3%) | 1 (0.6%) | 1 (2%) | 1 (0%) |
| Education | |||||
| Primary school or less | 177 (43%) | 166 (44%) | 106 (65%) | 41 (79%) | 1,427 (15%) |
| Basic high school | 209 (51%) | 180 (48%) | 53 (33%) | 10 (19%) | 6,152 (64%) |
| Advanced high school | 23 (6%) | 29 (8%) | 3 (2%) | 1 (2%) | 2,035 (21%) |
| Missing | 2 (0.5%) | 14 (0.1%) | |||
| Marital status | |||||
| Not married | 47 (11%) | 60 (16%) | 4 (2%) | 3 (6%) | 2,023 (21%) |
| Married/registered partnership | 318 (78%) | 289 (77%) | 139 (86%) | 41 (79%) | 6,359 (66%) |
| Divorced | 27 (7%) | 16 (4%) | 7 (4%) | 4 (8%) | 496 (5%) |
| Widowed | 15 (4%) | 7 (2%) | 11 (7%) | 2 (4%) | 740 (8%) |
| Missing | 2 (0.5%) | 5 (1%) | 1 (0.6%) | 2 (4%) | 10 (0.1%) |
| Comorbidity | |||||
| None | 158 (39%) | 165 (44%) | 47 (29%) | 18 (35%) | 3,358 (35%) |
| One | 83 (20%) | 103 (27%) | 36 (22%) | 18 (35%) | 2,669 (28%) |
| Two or more | 168 (41%) | 109 (29%) | 79 (49%) | 16 (31%) | 3,601 (37%) |
| Country of birth | |||||
| The Netherlands | 57 (14% | 40 (11%) | 7 (4%) | 1 (2%) | |
| Turkey/Morocco/else | 352 (86%) | 337 (89%) | 155 (96% | 51 (98%) | |
| Reason of immigration | |||||
| Work/reunion with spouse | 192 (47%) | 180 (48%) | 110 (68%) | 38 (73%) | |
| Children came with parents | 132 (32%) | 117 (31%) | 36 (22%) | 10 (19%) | |
| Other | 28 (7%) | 38 (10%) | 9 (6%) | 3 (6%) | |
| Missing | 57 (14%) | 42 (11%) | 7 (4%) | 1 (2%) | |
| Mother language | |||||
| Turkish | 344 (84%) | 152 (94%) | |||
| Kurdish | 8 (2%) | 1 (1%) | |||
| Other Turkish | 9 (2%) | 2 (1%) | |||
| Dutch | 48 (12%) | 62 (16%) | 7 (4%) | 1 (2%) | |
| Moroccan-Arabic | 195 (52%) | 43 (83%) | |||
| Tarifit | 40 (11%) | 4 (8%) | |||
| Tamazight | 67 (18%) | 4 (8%) | |||
| Tachelit | 6 (2%) | – | |||
| Other Moroccan | 7 (2%) | – | |||
| Proficiency in speaking Dutch | |||||
| None | 24 (6%) | 18 (5%) | 20 (12%) | 10 (19%) | |
| Low | 120 (29%) | 88 (23%) | 98 (61%) | 34 (65%) | |
| Moderate | 105 (26%) | 114 (30%) | 26 (16%) | 4 (8%) | |
| High | 160 (39%) | 156 (41%) | 18 (11%) | 4 (8%) | |
| Missing | 1 (0.3%) | ||||
Comorbidity = one or more of the following self-reported conditions: diabetes, stroke, myocardial infarction, myocardial disorder, cancer, migraine/severe headache, high blood pressure, vascular disorder, asthma/COPD, psoriasis, chronic eczema, dizziness/fall, intestine disorder, incontinence, back disorder, osteoarthritis (hip/knee), rheumatoid arthritis, neck/shoulder disorder, arm/hand disorder, and other chronic condition
aTurkish respondents who completed the SF-36 in Turkish
bMoroccan respondents who completed the SF-36 in Moroccan-Arabic
Median, mean, standard deviation, percentage floor and ceiling, and Cronbach’s α for the SF-36 scales
| Turkish ( | Turkish subgroup ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Median | Mean | SD | % Floor | % Ceiling | Cronbach’s α ( | Cronbach’s α ( | ||
| PF | 408 | 90.0 | 80.4 | 24.9 | 1.0 | 38.5 | 0.93 (397) | 0.92 (159) |
| RP | 408 | 100.0 | 70.8 | 41.0 | 19.6 | 61.0 | 0.93 (404) | 0.92 (160) |
| BP | 409 | 74.0 | 70.9 | 31.9 | 4.4 | 45.0 | 0.95 (403) | 0.95 (159) |
| GH | 408 | 65.0 | 60.2 | 23.0 | 1.0 | 2.2 | 0.81 (405) | 0.82 (160) |
| VT | 408 | 55.0 | 53.8 | 22.2 | 1.5 | 1.0 | 0.76 (404) | 0.73 (158) |
| SF | 409 | 87.5 | 75.6 | 26.7 | 2.4 | 38.1 | 0.77 (401) | 0.78 (162) |
| RE | 406 | 100.0 | 75.0 | 39.1 | 17.2 | 67.2 | 0.89 (403) | 0.90 (160) |
| MH | 408 | 68.0 | 64.5 | 21.2 | 1.2 | 2.2 | 0.81 (397) | 0.80 (157) |
Scales: PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health
a8 Dutch respondents were excluded due to large numbers of missing items
bDeviant (0.07 or more) from total Turkish or Moroccan population
Results of confirmatory factor analysis
| SF-36 item | Loading | |||
|---|---|---|---|---|
| Turkish ( | Moroccan ( | Dutch ( | ||
| PF by | PF1 Vigorous activities | 0.892 | 0.864 | 0.880 |
| PF2 Moderate activities | 0.906 | 0.874 | 0.934 | |
| PF3 Lifting/carrying | 0.912 | 0.881 | 0.904 | |
| PF4 Climbing several stairs | 0.914 | 0.936 | 0.956 | |
| PF5 Climbing 1 flight stairs | 0.896 | 0.929 | 0.970 | |
| PF6 Bending/kneeling | 0.893 | 0.868 | 0.861 | |
| PF7 Walking a km | 0.919 | 0.916 | 0.920 | |
| PF8 Walking few 100 m | 0.964 | 0.940 | 0.966 | |
| PF9 Walking 100 m | 0.918 | 0.891 | 0.987 | |
| PF10 Bathing/dressing | 0.823 | 0.787 | 0.849 | |
| RP by | RP1 Cut down time | 0.957 | 0.945 | 0.928 |
| PR2 Accomplished less | 0.967 | 0.923 | 0.945 | |
| RP3 Limited in kind | 0.990 | 0.974 | 0.977 | |
| PP4 Difficulty performing | 0.971 | 0.981 | 0.978 | |
| BP by | BP1 Pain | 0.949 | 0.971 | 0.933 |
| BP2 Pain interfere | 0.995 | 0.960 | 0.993 | |
| GH by | GH1 General health | 0.850 | 0.898 | 0.846 |
| GH2 Easier sick | 0.615 | 0.696 | 0.634 | |
| GH3 As healthy | 0.633 | 0.635 | 0.596 | |
| GH4 Health get worse | 0.615 | 0.581 | 0.501 | |
| GH5 Health excellent | 0.884 | 0.863 | 0.925 | |
| VT by | VT1 Full of pep | 0.485 | 0.155 | 0.682 |
| VT2 A lot of energy | 0.795 | 0.631 | 0.811 | |
| VT3 Worn out | 0.777 | 0.794 | 0.743 | |
| VT4 Tired | 0.747 | 0.738 | 0.759 | |
| SF by | SF1 Social-extent | 0.886 | 0.849 | 0.889 |
| SF2 Social-time | 0.834 | 0.861 | 0.873 | |
| RE by | RE1 Cut down time | 0.975 | 0.975 | 0.959 |
| RE2 Accomplished less | 0.978 | 0.972 | 0.993 | |
| RE3 Not careful | 0.914 | 0.967 | 0.855 | |
| MH by | MH1 Nervous | 0.617 | 0.717 | 0.663 |
| MH2 Down in dumps | 0.840 | 0.913 | 0.845 | |
| MH3 Calm and peaceful | 0.660 | 0.554 | 0.727 | |
| MH4 Downhearted/blue | 0.861 | 0.902 | 0.848 | |
| MH5 Happy | 0.601 | 0.629 | 0.704 | |
aAfter some restrictions (correlation between factor VT and MH fixed at 0.95 and error variance of item RE1 fixed at 0.05)
Summary of known-group comparisons (Student’s t test and ANOVA)
| Sex | Age | Marital status | Education | Comorbidity | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ∆ (BI) | ES | ∆ (BI) | ES | ∆ (BI) | ES | ∆ (BI) | ES | ∆ (BI) | ES | |
| Turkish sample ( | ||||||||||
| PF | 9.5 (4.7–14.3)* | 0.42 | 32.4 (27.0–37.7)* | 1.70 | 0.8 (−5.1 to 6.7) | 0.03 | 16.7 (12.0–21.3)* | 0.86 | 25.4 (21.2–29.7)* | 1.60 |
| RP | 12.0 (4.1–19.9)* | 0.33 | 23.9 (14.0–33.9)* | 0.61 | 1.2 (−8.5 to 10.8) | 0.03 | 16.3 (8.4–24.3)* | 0.43 | 35.8 (28.5–43.1)* | 1.14 |
| BP | 16.1 (10.1–22.2)* | 0.56 | 22.1 (14.4–29.7)* | 0.75 | 1.4 (−6.1 to 8.9) | 0.05 | 14.9 (8.8–21.0)* | 0.53 | 36.3 (31.0–41.5)* | 1.67 |
| GH | 9.6 (5.2–14.0)* | 0.43 | 22.4 (17.1–27.7)* | 1.06 | 0.5 (−5.0 to 5.9) | 0.02 | 14.9 (10.6–19.2)* | 0.73 | 26.7 (23.0–30.5)* | 1.55 |
| VT | 12.3 (8.1–16.4)* | 0.61 | 13.0 (7.6–18.4)* | 0.60 | 1.1 (−4.1 to 6.3) | 0.05 | 12.1 (7.9–16.3)* | 0.60 | 19.9 (15.9–23.8)* | 1.05 |
| SF | 11.2 (6.1–16.3)* | 0.46 | 20.4 (14.0–26.7)* | 0.83 | 4.2 (−2.1 to 10.5) | 0.16 | 11.7 (6.5–16.8)* | 0.47 | 22.8 (18.0–27.5)* | 1.15 |
| RE | 13.3 (5.8–20.9)* | 0.39 | 24.2 (14.7–33.6)* | 0.68 | 4.8 (−4.4 to 14.1) | 0.12 | 14.0 (6.5–21.6)* | 0.41 | 30.2 (23.0–37.4)* | 1.02 |
| MH | 10.1 (6.1–14.1)* | 0.53 | 7.2 (1.9–12.4)* | 0.34 | 2.3 (−2.7 to 7.3) | 0.11 | 7.1 (3.0–11.2)* | 0.36 | 17.6 (13.8–21.4)* | 1.05 |
| Moroccan sample ( | ||||||||||
| PF | 4.7 (0.7–8.6)* | 0.28 | 13.6 (8.4–18.9)* | 0.72 | −3.6 (−8.4 to 1.2) | −0.18 | 8.7 (4.8–12.6)* | 0.51 | 16.6 (12.5–20.6)* | 1.17 |
| RP | 8.5 (1.1–16.0)* | 0.25 | 6.5 (−3.7–16.8) | 0.18 | −5.7 (−14.8 to 3.4) | −0.15 | 2.5 (−5.1–10.1) | 0.07 | 33.3 (25.7–40.8)* | 1.14 |
| BP | 8.1 (2.2–14.1)* | 0.29 | 12.9 (4.8–21.0)* | 0.44 | −4.4 (−11.7 to 2.9) | −0.15 | 11.5 (5.5–17.4)* | 0.42 | 31.4 (25.6–37.2)* | 1.32 |
| GH | 4.1 (−0.5–8.7) | 0.18 | 16.7 (10.6–22.8)* | 0.75 | −6.9 (−12.4 to −1.3)*! | −0.31 | 13.1 (8.6–17.5)* | 0.61 | 22.7 (18.1–27.2)* | 1.12 |
| VT | 7.4 (3.7–11.1)* | 0.40 | 6.3 (1.2–11.4)* | 0.34 | −5.5 (−10.0 to −1.0)*! | −0.31 | 6.5 (2.7–10.2)* | 0.35 | 15.6 (11.8–19.5)* | 0.88 |
| SF | 6.7 (2.0–11.4)* | 0.31 | 10.9 (4.5–17.2)* | 0.47 | −0.5 (−6.2 to 5.2) | −0.02 | 6.0 (1.3–10.7)* | 0.26 | 18.5 (13.7–23.4)* | 0.94 |
| RE | 7.0 (−0.2–14.2) | 0.22 | −0.2 (−10.1–9.6) | −0.01 | 6.5 (−2.2 to 15.1) | 0.19 | 2.4 (−4.8–9.7) | 0.07 | 25.0 (17.5–32.6)* | 0.89 |
| MH | 5.5 (1.5–9.5)* | 0.28 | 6.4 (0.9–11.9)* | 0.32 | 2.5 (−2.4 to 7.3) | 0.13 | 4.0 (−0.1–8.1) | 0.20 | 15.7 (11.5–19.9)* | 0.89 |
| Dutch sample ( | ||||||||||
| PF | 4.8 (4.0–5.7)* | 0.24 | 13.5 (12.7–14.4)* | 0.89 | 2.7 (1.7–3.6)* | 0.13 | 16.9 (15.7–18.1)* | 0.88 | 20.1 (19.3–21.0)* | 1.47 |
| RP | 7.6 (6.2–9.0)* | 0.23 | 3.4 (2.0–4.8)* | 0.10 | 2.4 (0.9–3.9)* | 0.07 | 8.4 (6.4–10.4)* | 0.24 | 23.3 (21.9–24.7)* | 0.83 |
| BP | 7.1 (6.1–8.1)* | 0.31 | 5.0 (4.0–5.9)* | 0.21 | 1.6 (0.6–2.7)* | 0.07 | 7.4 (6.0–8.8) * | 0.31 | 20.6 (19.6–21.5)* | 1.05 |
| GH | 2.2 (1.4–3.0)* | 0.11 | 10.0 (9.2–10.8)* | 0.53 | 1.5 (0.6–2.3)* | 0.07 | 11.1 (10.0–12.2)* | 0.56 | 19.1 (18.3–19.8)* | 1.20 |
| VT | 6.2 (5.4–6.9)* | 0.34 | 0.2 (–0.6–0.9) | 0.01 | 3.8 (3.1–4.6)* | 0.20 | 6.0 (5.0–7.1) * | 0.33 | 12.3 (11.5–13.0)* | 0.75 |
| SF | 5.8 (4.9–6.6)* | 0.30 | 2.0 (1.2–2.9)* | 0.10 | 4.1 (3.2–5.0)* | 0.20 | 5.8 (4.6–7.0)* | 0.28 | 12.6 (11.8–13.5)* | 0.75 |
| RE | 4.2 (3.1–5.3)* | 0.18 | –0.8 (−1.8–0.3) | −0.03 | 3.7 (2.6–4.9)* | 0.15 | 1.8 (0.3–3.3)* | 0.07 | 8.9 (7.8–10.0)* | 0.41 |
| MH | 5.3 (4.7–6.0)* | 0.37 | 1.3 (0.7–1.9)* | 0.09 | 5.4 (4.7–6.1)* | 0.37 | 6.3 (5.4–7.2)* | 0.42 | 7.5 (6.9–8.2)* | 0.55 |
Sex = male minus female; Age = young minus old; Martial status = married/registered partnership minus not married/no registered partnership; Education = high school minus primary school; Comorbidity = none or one condition minus 2 or more conditions; ES = effect size
* P < 0.05
*! Statistically significant in the opposite direction to what had been hypothesized
Results of uniform and nonuniform DIF by ordinal regression analysis: odds ratio (β), confidence interval, and P-values of the Dutch sample (N = 9,620) vs. the Turkish or Moroccan sample
| Turkish | Moroccan | |||
|---|---|---|---|---|
| OR | OR | |||
| PF scale | ||||
| PF1 | 0.000 | 0.000** | ||
| PF2 | 1.07 (0.78–1.48)** | 0.669 | 0.64 (0.46–0.89) | 0.008 |
| PF3 | 0.80 (0.60–1.07) | 0.132 | 0.89 (0.66–1.22) | 0.478 |
| PF4 | 0.74 (0.54–1.02) | 0.066 | 0.79 (0.56–1.13) | 0.194 |
| PF5 | 1.01 (0.68–1.50) | 0.950 | 0.82 (0.51–1.30) | 0.395 |
| PF6 | 1.70 (1.25–2.32) | 0.001 | 1.02 (0.75–1.40) | 0.894 |
| PF7 | 0.000 | 0.55 (0.39–0.79) | 0.001 | |
| PF8 | 0.000 | 0.55 (0.35–0.88) | 0.013 | |
| PF9 | 0.68 (0.43–1.08) | 0.101 | 0.010 | |
| PF10 | 0.62 (0.39–0.99) | 0.045 | 0.74 (0.38–1.43) | 0.364 |
| RP scale | ||||
| RP1 | 0.000 | 1.47 (0.82–2.64) | 0.197 | |
| RP2 | 0.000 | 0.62 (0.35–1.09) | 0.095 | |
| RP3 | 1.29 (0.65–2.56) | 0.468 | 0.94 (0.47–1.90) | 0.871 |
| RP4 | 0.58 (0.34–0.99) | 0.045 | 0.75 (0.42–1.34) | 0.326 |
| BP scale | ||||
| BP1 | 1.17 (0.83–1.67) | 0.372 | 1.28 (0.88–1.85) | 0.193 |
| BP2 | 1.09 (0.80–1.50) | 0.581 | 1.16 (0.83–1.63) | 0.391 |
| GH scale | ||||
| GH1 | 0.81 (0.65–1.00)** | 0.050 | 0.89 (0.71–1.11) | 0.295** |
| GH2 | 0.56 (0.46–0.68) | 0.000 | 0.67 (0.54–0.82) | 0.000 |
| GH3 | 1.85 (1.52–2.26) | 0.000 | 1.83 (1.49–2.25) | 0.000 |
| GH4 | 0.93 (0.77–1.12) | 0.448 | 0.85 (0.70–1.03) | 0.103 |
| GH5 | 1.22 (0.98–1.53) | 0.079 | 1.31 (1.04–1.66) | 0.023 |
| VT scale | ||||
| VT1 | 0.64 (0.53–0.77)** | 0.000 | 0.000 | |
| VT2 | 1.22 (1.00–1.50) | 0.051 | 0.93 (0.75–1.14) | 0.478 |
| VT3 | 1.05 (0.86–1.28) | 0.623 | 0.000 | |
| VT4 | 0.000 | 0.000 | ||
| SF scale | ||||
| SF1 | 1.28 (0.97–1.70) | 0.079 | 1.76 (1.30–2.38) | 0.000 |
| SF2 | 0.78 (0.60–1.02) | 0.074 | 0.57 (0.43–0.74) | 0.000 |
| RE scale | ||||
| RE1 | 0.050 | 0.002 | ||
| RE2 | 0.86 (0.44–1.71) | 0.674 | 0.70 (0.31–1.56) | 0.381 |
| RE3 | 0.63 (0.37–1.06) | 0.084 | 0.78 (0.42–1.48) | 0.453 |
| MH scale | ||||
| MH1 | 1.46 (1.19–1.78) | 0.000 | 0.000 | |
| MH2 | 0.56 (0.45–0.69) | 0.000 | 0.71 (0.56–0.89) | 0.003 |
| MH3 | 1.34 (1.09–1.64)** | 0.005 | 0.70 (0.57–0.86) | 0.001** |
| MH4 | 0.70 (0.57–0.86) | 0.001 | 1.42 (1.14–1.77) | 0.002 |
| MH5 | 1.69 (1.39–2.07)** | 0.000 | 0.98 (0.80–1.20) | 0.864 |
All analyses were corrected for age, sex, and comorbidity
Log odds ratio = eEstimate ± 1.96*SE
Uniform DIF for language was considered to be present if the odds ratio is outside the interval of 0.53–1.89 and is presented in bold
Nonuniform DIF was considered to be present if the interaction of language with the total score was found to be statistically significant (P ≤ 0.001) and is presented in the table with an **